|
시장보고서
상품코드
2050950
재조합 단백질 시장 : 제품 유형별, 발현 시스템별, 용도별, 최종사용자별, 지역별Recombinant Protein Market, by Product Type, by Expression System, by Application, by End User, by Region |
||||||
재조합 단백질 시장은 2026년에 43억 4,790만 달러로 추정되며, 2033년까지 94억 3,310만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 11.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 43억 4,790만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 11.70% | 2033년 시장 규모 예측 : | 94억 3,310만 달러 |
재조합 단백질은 유전자 발현과 메신저 RNA의 번역을 가능하게 하는 발현 벡터에 클로닝된 재조합 DNA에 의해 코딩된 단백질입니다. 재조합 DNA 기술에 의한 유전자 변형은 돌연변이 단백질의 생산을 초래할 수 있습니다. 재조합 단백질은 단백질 생산량을 늘리고 유전자 서열을 변형하여 유용한 제품을 생산하기 위해 다양한 방법으로 제조되는 천연 단백질의 변형된 형태입니다.
많은 재조합 단백질은 당쇄 추가와 같은 번역 후 변형이 필요하며, 이러한 변형은 진핵생물, 효모, 포유류, 곤충의 세포 배양 시스템에서만 가능합니다. HEK293 유래 세포주는 일시적인 단백질 생산에 사용됩니다. 현재 대부분의 재조합 치료용 단백질은 천연 단백질과 유사한 고품질 단백질을 생산할 수 있는 능력이 있기 때문에 포유류 세포에서 생산되고 있습니다. 또한, 많은 승인된 재조합 치료용 단백질은 유전학적 특성이 잘 밝혀져 있고, 증식이 빠르며, 높은 수율로 생산할 수 있기 때문에 대장균으로 생산되고 있습니다.
시장 역학
회사는 세계 시장에서 확고한 입지를 구축하기 위해 인수 및 제휴 등의 전략에 집중하고 있습니다. 예를 들어, 2022년 12월 써모피셔 사이언티픽은 재조합 단백질 개발 및 제조 기업인 페프로텍(Peprotech)을 인수했습니다. 이번 인수로 써모피셔 사이언티픽은 재조합 단백질 포트폴리오를 강화할 수 있게 됐습니다.
규제 당국의 재조합 호르몬 생물학적 제제 승인 신청 건수 증가는 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 1월, 다국적 제약 및 생명공학 기업 화이자와 생명공학 기업 OPKO 헬스(OPKO Health)는 미국 식품의약국(FDA)이 소마트로그의 생물학적 제제 승인 신청(BLA)에 대해 CRL(Complete Response Letter)을 발행했다고 발표했습니다. 소마트로그는 소아 환자의 성장호르몬 결핍증(GHD) 치료를 목적으로 하는 주 1회 투여하는 장기지속형 재조합 인간성장호르몬 임상시험용 의약품입니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트도 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 재조합 단백질 시장의 주요 기업 프로파일을 작성했습니다. 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략입니다. 본 조사에 포함된 주요 기업으로는 Merck KGaA, OriGene Technologies, Inc. Randox Laboratories Ltd., SOL 그룹(SOL GROUP), Proteintech Group, Inc. Infinite Enzymes, Infinite Enzymes, Infinite Enzymes, Infinite Enzymes, ORF Genetics, GenScript, BTL Biotechno Labs, BTL Biotechno Labs Pvt Ltd. 프로스펙타니 테크노진(Prospec-Tany Technogene Ltd.), BPS 바이오사이언스(BPS Bioscience, Inc.), 시노 바이오로지컬(Sino Biological), 케이프 바이오 파마(Cape Bio Pharms), 아노바 코퍼레이션(Abnova Corporation), 지넥스트 지노믹스(GeNext Genomics) 등이 포함됩니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 개선, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 재조합 단백질 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 재조합 단백질 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 재조합 단백질 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 재조합 단백질 시장 : 발현 시스템별, 2021년-2033년
제6장 세계의 재조합 단백질 시장 : 용도별, 2021년-2033년
제7장 세계의 재조합 단백질 시장 : 최종사용자별, 2021년-2033년
제8장 세계의 재조합 단백질 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.06.15Recombinant Protein Market is estimated to be valued at USD 4,347.9 Mn in 2026 and is expected to reach USD 9,433.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4,347.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.70% | 2033 Value Projection: | USD 9,433.1 Mn |
A recombinant protein is a protein encoded by recombinant DNA cloned into an expression vector that supports gene expression and translation of messenger RNA. Modification of genes by recombinant DNA techniques can result in the expression of mutant proteins. Recombinant proteins are engineered forms of natural proteins that are produced in a variety of ways to increase protein production, alter genetic sequences, and produce useful commodities.
Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high quality proteins similar to those in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.
Market Dynamics
The company is focused on adopting strategies such as acquisitions and collaborations to gain strong foothold in the global market. For instance, in December, 2022, Thermo Fischer Scientific Inc. acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. to strengthen its recombinant proteins portfolio.
The increasing approvals for the biologics license application of recombinant hormones from the regulatory bodies is expected to drive the market growth over the forecast period. For instance, in January 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology Company, and OPKO Health, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global recombinant protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant protein market.
Market Segmentation
- Global Recombinant Protein Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Antibodies
- Antigens
- Enzymes
- Hormones
- Others
- Global Recombinant Protein Market, By Expression System (Revenue, USD Mn, 2021 - 2033)
- Microbes
- Plant
- Animal
- Global Recombinant Protein Market By Application (Revenue, USD Mn, 2021 - 2033)
- Drug Discovery and Development
- Research Application
- Therapeutic Use
- Diagnostics
- Others
- Global Recombinant Protein Market By End User (Revenue, USD Mn, 2021 - 2033)
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institute
- Contract Research Organization
- Others
- Global Recombinant Protein Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck KGaA
- OriGene Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Feldan Therapeutics
- ACROBiosystems
- Abcam plc.
- Randox Laboratories Ltd.
- SOL GROUP
- Proteintech Group, Inc
- Planet Biotechnology, Inc.
- INFINITE ENZYMES, INC.
- ORF Genetics
- GenScript
- BTL Biotechno Labs Pvt Ltd.
- Prospec-Tany Technogene Ltd.
- BPS Bioscience, Inc.
- Sino Biological
- Cape Bio Pharms
- Abnova Corporation
- GeNext Genomics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Expression System
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Regulatory Guideline and Compliances
- Government Intervention
- PEST Analysis
- Technology Landscape
- Brand Attribute Mapping
- Investments
- Pricing Analysis (2022)
4. Global Recombinant Protein Market, By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Antigens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Recombinant Protein Market, By Expression System, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Microbes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Plant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Animal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Recombinant Protein Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Research Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Therapeutic Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Recombinant Protein Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Recombinant Protein Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OriGene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Feldan Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ACROBiosystems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abcam plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SOL GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Proteintech Group, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Planet Biotechnology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- INFINITE ENZYMES, INC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ORF Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BTL Biotechno Labs Pvt Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Prospec-Tany Technogene Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BPS Bioscience, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sino Biological
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cape Bio Pharms
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GeNext Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
